Published in Ann Intern Med on July 21, 2009
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet (2011) 5.21
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut (2012) 2.05
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett (2010) 1.31
Current management and future strategies of gastric cancer. Yonsei Med J (2012) 1.23
Gastric cancer: an infectious disease. Infect Dis Clin North Am (2010) 1.17
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev (2012) 1.13
Helicobacter pylori Infection and Gastric Adenocarcinoma. US Gastroenterol Hepatol Rev (2011) 1.12
The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol (2010) 1.11
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. Antimicrob Agents Chemother (2010) 1.10
Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil (2012) 1.09
Gastric carcinogenesis. Langenbecks Arch Surg (2011) 1.08
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA (2013) 1.07
The prevention of infection-associated cancers. Carcinogenesis (2011) 1.03
Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol (2014) 1.03
Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol (2011) 0.96
Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol (2010) 0.96
The stomach in health and disease. Gut (2015) 0.95
Medical management of gastric cancer: a 2014 update. World J Gastroenterol (2014) 0.94
Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Physiol Gastrointest Liver Physiol (2012) 0.93
Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol (2014) 0.93
Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench (2015) 0.91
H. pylori vaccines: why we still don't have any. Hum Vaccin (2011) 0.90
Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer. Oncogene (2011) 0.90
H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci (2010) 0.89
Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study. J Gastroenterol (2014) 0.88
Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis. PLoS One (2013) 0.88
Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila) (2013) 0.88
Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan. PLoS One (2014) 0.88
Management of Helicobacter pylori. F1000 Med Rep (2010) 0.87
Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008. Croat Med J (2012) 0.87
Management of Helicobacter pylori infection after gastric surgery. World J Gastroenterol (2014) 0.87
Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy. Gastroenterol Res Pract (2012) 0.87
Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy. Biomed Res Int (2015) 0.87
Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol (2014) 0.86
Diagnosis and management of high risk group for gastric cancer. Gut Liver (2015) 0.86
Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer. Sci Rep (2014) 0.85
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. Am J Gastroenterol (2016) 0.85
Helicobacter pylori: friend or foe? World J Gastroenterol (2014) 0.85
Advances in gastric cancer prevention. World J Clin Oncol (2012) 0.85
Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication. Biomed Res Int (2014) 0.84
Helicobacter pylori eradication for preventing gastric cancer. World J Gastroenterol (2014) 0.84
Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer. J Korean Med Sci (2015) 0.83
Simultaneous occurrence of early gastric carcinoma and mucosa-associated lymphoid tissue lymphoma of the omentum. Case Rep Gastroenterol (2014) 0.83
Serum pepsinogen and Helicobacter pylori infection--a Japanese population study. Eur J Clin Microbiol Infect Dis (2012) 0.83
Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis. World J Gastroenterol (2014) 0.83
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. Cancer Lett (2014) 0.83
Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis. World J Gastroenterol (2015) 0.82
Helicobacter pylori Antibody Titer and Gastric Cancer Screening. Dis Markers (2015) 0.82
Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes (2013) 0.82
Redundant data in the meta-analysis on Helicobacter pylori eradication. Ann Intern Med (2009) 0.82
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review. Clin Transl Gastroenterol (2013) 0.81
Rodent models of Helicobacter infection, inflammation, and disease. Methods Mol Biol (2012) 0.81
Gastrectomy and D2 Lymphadenectomy for Gastric Cancer: A Meta-Analysis Comparing the Harmonic Scalpel to Conventional Techniques. Int J Surg Oncol (2015) 0.81
New advances in targeted gastric cancer treatment. World J Gastroenterol (2016) 0.81
Epithelial Regeneration After Gastric Ulceration Causes Prolonged Cell-Type Alterations. Cell Mol Gastroenterol Hepatol (2016) 0.79
Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication. J Gastroenterol (2013) 0.79
Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesis. Oncotarget (2016) 0.79
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World J Gastroenterol (2012) 0.79
On the association between soft drink consumption and Helicobacter pylori infection. Dig Dis Sci (2011) 0.78
At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol (2014) 0.78
Malignancies after pediatric kidney transplantation: more than PTLD? Pediatr Nephrol (2013) 0.78
Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance. Biomed Res Int (2014) 0.78
Quadruple therapy for eradication of Helicobacter pylori. World J Gastroenterol (2013) 0.78
Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med (2013) 0.78
Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus. World J Gastroenterol (2014) 0.78
Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol (2014) 0.77
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics. Biomed Res Int (2015) 0.77
Etiology and Prevention of Gastric Cancer. Gastrointest Tumors (2016) 0.77
Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia. Endosc Int Open (2015) 0.77
Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid. PLoS One (2013) 0.77
Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial. Br J Cancer (2015) 0.76
The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease. Dig Dis Sci (2013) 0.76
Screening for and surveillance of gastric cancer. World J Gastroenterol (2014) 0.76
Clinical trial report: Eradication of Helicobacter pylori reduces the risk for subsequent gastric cancer. Curr Gastroenterol Rep (2010) 0.75
High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients. World J Gastrointest Pathophysiol (2016) 0.75
Efficacy of Helicobacter pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection for early gastric cancer. World J Gastroenterol (2014) 0.75
Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia. BMC Gastroenterol (2015) 0.75
Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol (2015) 0.75
Helicobacter pylori and immigrant health. CMAJ (2012) 0.75
Are we making progress in diagnosing and preventing gastrointestinal cancers? Therap Adv Gastroenterol (2010) 0.75
Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis (2017) 0.75
Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review. World J Gastroenterol (2014) 0.75
In vitro and In vivo Anti-Helicobacter pylori Activities of Centella asiatica Leaf Extract. Prev Nutr Food Sci (2016) 0.75
Anti-Helicobacter pylori Properties of GutGard™. Prev Nutr Food Sci (2013) 0.75
Serum Helicobacter pylori FliD antibody and the risk of gastric cancer. Oncotarget (2016) 0.75
Rapid (13)C Urea Breath Test to Identify Helicobacter pylori Infection in Emergency Department Patients with Upper Abdominal Pain. West J Emerg Med (2013) 0.75
Fas-associated factor 1 inhibits tumor growth by suppressing Helicobacter pylori-induced activation of NF-κB signaling in human gastric carcinoma. Oncotarget (2016) 0.75
Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study. Evid Based Complement Alternat Med (2013) 0.75
Combination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection. Gastroenterol Res Pract (2015) 0.75
Surveillance for gastrointestinal malignancies. World J Gastroenterol (2012) 0.75
Youngest case of an early gastric cancer after successful eradication therapy. World J Gastrointest Endosc (2013) 0.75
Contemporary Diagnostic Strategies for the Detection of Helicobacter pylori Infection. Gastroenterol Hepatol (N Y) (2012) 0.75
The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary. Epidemiol Infect (2015) 0.75
Endoscopic surveillance of gastric cancers after Helicobacter pylori eradication. World J Gastroenterol (2015) 0.75
The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis. PLoS One (2017) 0.75
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med (2007) 3.26
Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials. Am J Gastroenterol (2009) 2.84
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study. Gut (2006) 2.56
Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev (2013) 2.53
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00
Endoscopic ultrasound-guided fine needle aspiration with 22- and 25-gauge needles in solid pancreatic masses: a prospective comparative study with randomisation of needle sequence. Dig Liver Dis (2011) 1.96
Endoclip-assisted resection of large pedunculated colorectal polyps: technical aspects and outcome. Dig Dis Sci (2009) 1.85
Efficacy, safety and outcomes of 'inject and cut' endoscopic mucosal resection for large sessile and flat colorectal polyps. Digestion (2010) 1.82
Fully covered, self-expandable metal stents for first-step endoscopic treatment of biliary leaks secondary to hepato-biliary surgery: a retrospective study. Dig Liver Dis (2012) 1.71
Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study. Gastrointest Endosc (2009) 1.69
Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study. Am J Gastroenterol (2009) 1.58
Treatment of Helicobacter pylori infection. BMJ (2008) 1.56
Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc (2007) 1.51
Pneumatosis cystoides intestinalis. World J Gastroenterol (2011) 1.44
Investigating dyspepsia. BMJ (2008) 1.41
Guidelenines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society. World J Emerg Surg (2010) 1.39
WallFlex colonic stent placement for management of malignant colonic obstruction: a prospective study at two centers. Gastrointest Endosc (2008) 1.33
Epidemiology of Helicobacter pylori infection. Helicobacter (2014) 1.26
Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res (2003) 1.25
Endoscopic ultrasound-guided drainage of pancreatic fluid collections. World J Gastrointest Endosc (2012) 1.25
Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res (2003) 1.20
Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget (2011) 1.11
Meta-analysis of randomized trials comparing endoscopic stenting and surgical decompression for colorectal cancer obstruction. Int J Colorectal Dis (2012) 1.06
Avoidance of early needle knife sphincterotomy to achieve deep biliary cannulation is no longer justified. Clin Gastroenterol Hepatol (2013) 1.06
Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology (2010) 1.06
High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. Clin Cancer Res (2005) 1.04
Diagnosis and management of gastric antral vascular ectasia. World J Gastrointest Endosc (2013) 1.01
Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol (2010) 0.96
Side-viewing endoscope for colonic self-expandable metal stenting in patients with malignant colonic obstruction. Eur J Gastroenterol Hepatol (2009) 0.96
Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? Clin Gastroenterol Hepatol (2009) 0.95
13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter (2005) 0.95
A comparison of uncovered metal stents for the palliation of patients with malignant biliary obstruction: nitinol vs. stainless steel. Dig Liver Dis (2011) 0.94
Endoscopic ultrasound-guided fine-needle biopsy of small solid pancreatic lesions using a 22-gauge needle with side fenestration. Surg Endosc (2014) 0.91
Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle (2012) 0.91
The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc (2013) 0.91
A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents. Helicobacter (2002) 0.90
Contrast Harmonic-Endoscopic Ultrasound Is Useful to Identify Neoplastic Features of Pancreatic Cysts (With Videos). Pancreas (2016) 0.90
Fecal detection of Mycobacterium avium paratuberculosis using the IS900 DNA sequence in Crohn's disease and ulcerative colitis patients and healthy subjects. Dig Dis Sci (2011) 0.89
Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy. Int J Colorectal Dis (2003) 0.89
Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys. Clin Gastroenterol Hepatol (2012) 0.88
Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol (2009) 0.87
Through-the-scope large diameter self-expanding metal stent placement as a safe and effective technique for palliation of malignant colorectal obstruction: a single center experience with a long-term follow-up. Scand J Gastroenterol (2011) 0.87
Endoscopic ultrasound-fine needle aspiration diagnosis and treatment of a gastric intramural pseudocyst. Dig Liver Dis (2012) 0.85
Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? Best Pract Res Clin Gastroenterol (2011) 0.85
Phytochemicals and colorectal cancer prevention--myth or reality? Nat Rev Gastroenterol Hepatol (2011) 0.84
Single session versus separate session endoscopic ultrasonography plus endoscopic retrograde cholangiography in patients with low to moderate risk for choledocholithiasis. J Gastroenterol Hepatol (2009) 0.84
The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2009) 0.83
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer (2014) 0.83
Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases. Int J Surg Pathol (2013) 0.83
Inter-centre variability of the adenoma detection rate: a prospective, multicentre study. Dig Liver Dis (2013) 0.82
Endoscopic tattooing of gastrointestinal and pancreatic lesions. Adv Ther (2012) 0.82
What is the best salvage therapy for patients with Helicobacter pylori infection? Nat Clin Pract Gastroenterol Hepatol (2008) 0.79
EUS-FNA diagnosis of single pancreatic metastasis of liposarcoma. Gastrointest Endosc (2009) 0.79
Gastric cancer: who is at risk? Dig Dis (2004) 0.79
Clinical application of faecal calprotectin in ulcerative colitis patients. Eur J Gastroenterol Hepatol (2015) 0.79
Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning? Gastrointest Endosc (2010) 0.78
Colorectal stenting as a bridge to surgery reduces morbidity and mortality in left-sided malignant obstruction: a predictive risk score-based comparative study. Dig Liver Dis (2012) 0.78
Helicobacter pylori eradication treatment reduces but does not abolish the risk of gastric cancer. Am J Gastroenterol (2009) 0.77
Concerns on the very high complication rates reported after self-expanding metal stent (SEMS) placement for colorectal cancer in a Catalan retrospective study. Am J Gastroenterol (2010) 0.77
Is Helicobacter pylori the infectious target to prevent gastric cancer? An interdisciplinary point of view. Infect Disord Drug Targets (2012) 0.76
Preoperative diagnosis of a solid pseudopapillary tumour of the pancreas by Endoscopic Ultrasound Fine Needle Biopsy: A retrospective case series. Dig Liver Dis (2013) 0.76
World gastroenterology organisation global guidelines: dysphagia--global guidelines and cascades update September 2014. J Clin Gastroenterol (2015) 0.76
Treatment with telbivudine for fulminant hepatitis B. J Dig Dis (2013) 0.75
Performance of the forward-view echoendoscope for pancreaticobiliary examination in patients with status post-upper gastrointestinal surgery. Endosc Ultrasound (2015) 0.75
Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions. Am J Gastroenterol (2010) 0.75
Was it really an "ugly" meta-analysis? Am J Gastroenterol (2009) 0.75
Simultaneous EUS-FNA Diagnosis and TNM Staging of a Pancreatic Neuroendocrine Tumor in a Patient with an Unrecognized MEN Type 1. Case Rep Oncol Med (2012) 0.75